{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:43:56Z","timestamp":1792791836114,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T00:00:00Z","timestamp":1695772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Jonker-Driessen Foundation"},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["480-08-009"],"award-info":[{"award-number":["480-08-009"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["480-08-009"],"award-info":[{"award-number":["480-08-009"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["480-08-009"],"award-info":[{"award-number":["480-08-009"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11764-023-01458-2","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:03:37Z","timestamp":1695809017000},"page":"183-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The course of self-perceived cognitive functioning among patients with lymphoma and the co-occurrence with fatigue and psychological distress"],"prefix":"10.1007","volume":"19","author":[{"given":"Afke","family":"Ekels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Oerlemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne B.","family":"Schagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamila E.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noortje","family":"Thielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marten R.","family":"Nijziel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein W. M.","family":"van der Poel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy P. J.","family":"Arts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardus F. M.","family":"Posthuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke V.","family":"van de Poll-Franse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"issue":"3","key":"1458_CR1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00520-016-3480-z","volume":"25","author":"D Krolak","year":"2017","unstructured":"Krolak D, et al. Cognitive function and its relationship to other psychosocial factors in lymphoma survivors. Support Care Cancer. 2017;25(3):905\u201313.","journal-title":"Support Care Cancer"},{"issue":"2","key":"1458_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11764-021-01023-9","volume":"16","author":"S Oerlemans","year":"2022","unstructured":"Oerlemans S, et al. Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry. J Cancer Surviv. 2022;16(2):303\u201313.","journal-title":"J Cancer Surviv"},{"issue":"1","key":"1458_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2014.12.006","volume":"72","author":"XM Wang","year":"2015","unstructured":"Wang XM, et al. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine. 2015;72(1):86\u201396.","journal-title":"Cytokine"},{"key":"1458_CR4","doi-asserted-by":"crossref","first-page":"577769","DOI":"10.1016\/j.jneuroim.2021.577769","volume":"362","author":"MC Janelsins","year":"2022","unstructured":"Janelsins MC, et al. Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer. J Neuroimmunol. 2022;362:577769.","journal-title":"J Neuroimmunol"},{"issue":"5","key":"1458_CR5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/bjh.15448","volume":"182","author":"E Trachtenberg","year":"2018","unstructured":"Trachtenberg E, et al. Cognitive impairment in hodgkin lymphoma survivors. Br J Haematol. 2018;182(5):670\u20138.","journal-title":"Br J Haematol"},{"key":"1458_CR6","doi-asserted-by":"crossref","unstructured":"Janelsins MC et al. Longitudinal changes in cognitive function in a nationwide cohort study of patients with lymphoma treated with chemotherapy. J Natl Cancer Inst, 2021.","DOI":"10.1093\/jnci\/djab133"},{"issue":"5","key":"1458_CR7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/cancers11050687","volume":"11","author":"B Olson","year":"2019","unstructured":"Olson B, Marks DL. Pretreatment cancer-related cognitive impairment-mechanisms and outlook. Cancers (Basel). 2019;11(5):687.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"1458_CR8","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1007\/s00520-020-05857-4","volume":"29","author":"J Mariegaard","year":"2021","unstructured":"Mariegaard J, et al. Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors. Support Care Cancer. 2021;29(6):3319\u201328.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1458_CR9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/pon.5339","volume":"29","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, et al. Systematic review of longitudinal studies on chemotherapy-associated subjective cognitive impairment in cancer patients. Psychooncology. 2020;29(4):617\u201331.","journal-title":"Psychooncology"},{"issue":"29","key":"1458_CR10","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1200\/JCO.2011.39.5640","volume":"30","author":"HS Jim","year":"2012","unstructured":"Jim HS, et al. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. J Clin Oncol. 2012;30(29):3578\u201387.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1458_CR11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ctrv.2012.11.001","volume":"39","author":"KD Hodgson","year":"2013","unstructured":"Hodgson KD, et al. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treat Rev. 2013;39(3):297\u2013304.","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"1458_CR12","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1080\/10428194.2020.1728748","volume":"61","author":"AM Williams","year":"2020","unstructured":"Williams AM, et al. Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment. Leuk Lymphoma. 2020;61(7):1627\u201335.","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"1458_CR13","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","volume":"30","author":"M Lange","year":"2019","unstructured":"Lange M, et al. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors. Ann Oncol. 2019;30(12):1925\u201340.","journal-title":"Ann Oncol"},{"issue":"11","key":"1458_CR14","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1200\/JCO.2004.08.094","volume":"22","author":"IF Tannock","year":"2004","unstructured":"Tannock IF, et al. Cognitive impairment associated with chemotherapy for cancer: report of a workshop. J Clin Oncol. 2004;22(11):2233\u20139.","journal-title":"J Clin Oncol"},{"issue":"8","key":"1458_CR15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/13548506.2020.1770815","volume":"26","author":"B Muzzatti","year":"2021","unstructured":"Muzzatti B, et al. Cognitive function in long-term lymphoma survivors: relationship between subjective reports and objective assessments and with quality of life. Psychol Health Med. 2021;26(8):968\u201379.","journal-title":"Psychol Health Med"},{"issue":"2","key":"1458_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/10428194.2014.915546","volume":"56","author":"P Zimmer","year":"2015","unstructured":"Zimmer P, et al. Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Leuk Lymphoma. 2015;56(2):347\u201352.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"1458_CR17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamaoncol.2017.5674","volume":"4","author":"TT Hshieh","year":"2018","unstructured":"Hshieh TT, et al. Prevalence of cognitive impairment and association with survival among older patients with hematologic cancers. JAMA Oncol. 2018;4(5):686\u201393.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1458_CR18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.2002.20.2.485","volume":"20","author":"TA Ahles","year":"2002","unstructured":"Ahles TA, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002;20(2):485\u201393.","journal-title":"J Clin Oncol"},{"key":"1458_CR19","doi-asserted-by":"crossref","unstructured":"Franceschetti S et al. Late neurological and cognitive sequelae and long-term monitoring of classical Hodgkin lymphoma and diffuse large B-cell lymphoma survivors: a systematic review by the Fondazione Italiana Linfomi. Cancers (Basel), 2021. 13(14)","DOI":"10.3390\/cancers13143401"},{"issue":"14","key":"1458_CR20","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ejca.2011.04.034","volume":"47","author":"LV van de Poll-Franse","year":"2011","unstructured":"van de Poll-Franse LV, et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14):2188\u201394.","journal-title":"Eur J Cancer"},{"key":"1458_CR21","unstructured":"Jack A et al. International classification of diseases for oncology: ICD-O. 2000: World Health Organization."},{"issue":"1","key":"1458_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13063-017-1943-2","volume":"18","author":"LPJ Arts","year":"2017","unstructured":"Arts LPJ, et al. Lymphoma InterVEntion (LIVE) - patient-reported outcome feedback and a web-based self-management intervention for patients with lymphoma: study protocol for a randomised controlled trial. Trials. 2017;18(1):199.","journal-title":"Trials"},{"issue":"5","key":"1458_CR23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ejca.2010.11.004","volume":"47","author":"LV van de Poll-Franse","year":"2011","unstructured":"van de Poll-Franse LV, et al. Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch population. Eur J Cancer. 2011;47(5):667\u201375.","journal-title":"Eur J Cancer"},{"issue":"5","key":"1458_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI: J Nat Cancer Institute. 1993;85(5):365\u201376.","journal-title":"JNCI: J Nat Cancer Institute"},{"issue":"2","key":"1458_CR25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11136-017-1718-y","volume":"27","author":"L van de Poll-Franse","year":"2018","unstructured":"van de Poll-Franse L, et al. International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia. Qual Life Res. 2018;27(2):333\u201345.","journal-title":"Qual Life Res"},{"key":"1458_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.10.003","volume":"118","author":"JM Giesinger","year":"2020","unstructured":"Giesinger JM, et al. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. J Clin Epidemiol. 2020;118:1\u20138.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"1458_CR27","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.ejca.2012.02.059","volume":"48","author":"K Cocks","year":"2012","unstructured":"Cocks K, et al. Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Eur J Cancer. 2012;48(11):1713\u201321.","journal-title":"Eur J Cancer"},{"issue":"6","key":"1458_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370.","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"1458_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2002","unstructured":"Bjelland I, et al. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69\u201377.","journal-title":"J Psychosom Res"},{"issue":"6","key":"1458_CR30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6604952","volume":"100","author":"S Singer","year":"2009","unstructured":"Singer S, et al. Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer. 2009;100(6):908\u201312.","journal-title":"Br J Cancer"},{"issue":"2","key":"1458_CR31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/art.10993","volume":"49","author":"O Sangha","year":"2003","unstructured":"Sangha O, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Care Res. 2003;49(2):156\u201363.","journal-title":"Arthritis Care Res"},{"key":"1458_CR32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1100\/tsw.2011.2","volume":"11","author":"DT Shek","year":"2011","unstructured":"Shek DT, Ma CM. Longitudinal data analyses using linear mixed models in SPSS: concepts, procedures and illustrations. Sci World J. 2011;11:42\u201376.","journal-title":"Sci World J"},{"issue":"1","key":"1458_CR33","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41598-018-36973-1","volume":"9","author":"N Papachristou","year":"2019","unstructured":"Papachristou N, et al. Network analysis of the multidimensional symptom experience of oncology. Sci Rep. 2019;9(1):2258.","journal-title":"Sci Rep"},{"issue":"1","key":"1458_CR34","doi-asserted-by":"crossref","first-page":"17052","DOI":"10.1038\/s41598-022-21140-4","volume":"12","author":"E Kalantari","year":"2022","unstructured":"Kalantari E, et al. Network analysis to identify symptoms clusters and temporal interconnections in oncology patients. Sci Rep. 2022;12(1):17052.","journal-title":"Sci Rep"},{"issue":"2","key":"1458_CR35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1742395319836472","volume":"17","author":"V Menzies","year":"2021","unstructured":"Menzies V, et al. A systematic review of the association between fatigue and cognition in chronic noncommunicable diseases. Chronic Illn. 2021;17(2):129\u201350.","journal-title":"Chronic Illn"},{"key":"1458_CR36","doi-asserted-by":"crossref","first-page":"120162","DOI":"10.1016\/j.jns.2022.120162","volume":"434","author":"L Premraj","year":"2022","unstructured":"Premraj L, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162.","journal-title":"J Neurol Sci"},{"issue":"24","key":"1458_CR37","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1002\/cncr.33852","volume":"127","author":"BH de Rooij","year":"2021","unstructured":"de Rooij BH, et al. Symptom clusters in 1330 survivors of 7 cancer types from the PROFILES registry: a network analysis. Cancer. 2021;127(24):4665\u201374.","journal-title":"Cancer"},{"issue":"5","key":"1458_CR38","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/bjh.18139","volume":"197","author":"A Ekels","year":"2022","unstructured":"Ekels A, et al. Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: a longitudinal PROFILES registry study. Br J Haematol. 2022;197(5):590\u2013601.","journal-title":"Br J Haematol"},{"key":"1458_CR39","doi-asserted-by":"crossref","unstructured":"Kiserud CE et al. Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data. Leuk Lymphoma, 2022:1\u20137","DOI":"10.1080\/10428194.2022.2142050"},{"issue":"4","key":"1458_CR40","doi-asserted-by":"crossref","first-page":"djw253","DOI":"10.1093\/jnci\/djw253","volume":"109","author":"C Miaskowski","year":"2017","unstructured":"Miaskowski C, et al. Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations. J Natl Cancer Inst. 2017;109(4):djw253.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"1458_CR41","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1007\/s00520-017-3766-9","volume":"25","author":"D Oberoi","year":"2017","unstructured":"Oberoi D, et al. The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers. Support Care Cancer. 2017;25(11):3447\u201356.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1458_CR42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.soncn.2016.08.006","volume":"32","author":"C Miaskowski","year":"2016","unstructured":"Miaskowski C. Future Directions in Symptom Cluster Research. Semin Oncol Nurs. 2016;32(4):405\u201315.","journal-title":"Semin Oncol Nurs"},{"issue":"8","key":"1458_CR43","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/0284186X.2020.1759823","volume":"59","author":"D Schoormans","year":"2020","unstructured":"Schoormans D, et al. Negative illness perceptions are related to more fatigue among haematological cancer survivors: a PROFILES study. Acta Oncol. 2020;59(8):959\u201366.","journal-title":"Acta Oncol"},{"issue":"6","key":"1458_CR44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34(6):557\u201365.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1458_CR45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","volume":"18","author":"E Basch","year":"2021","unstructured":"Basch E, et al. Composite grading algorithm for the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials. 2021;18(1):104\u201314.","journal-title":"Clin Trials"},{"issue":"29","key":"1458_CR46","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1200\/JCO.20.03514","volume":"39","author":"EA Salerno","year":"2021","unstructured":"Salerno EA, et al. Physical activity patterns and relationships with cognitive function in patients with breast cancer before, during, and after chemotherapy in a prospective, nationwide study. J Clin Oncol. 2021;39(29):3283\u201392.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1458_CR47","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1080\/0284186X.2021.1962543","volume":"60","author":"S Belloni","year":"2021","unstructured":"Belloni S, Arrigoni C, Caruso R. Effects from physical exercise on reduced cancer-related fatigue: a systematic review of systematic reviews and meta-analysis. Acta Oncol. 2021;60(12):1678\u201387.","journal-title":"Acta Oncol"},{"issue":"7","key":"1458_CR48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","volume":"3","author":"KM Mustian","year":"2017","unstructured":"Mustian KM, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis. JAMA Oncol. 2017;3(7):961\u20138.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1458_CR49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11764-019-00839-w","volume":"14","author":"JK Ehrenstein","year":"2020","unstructured":"Ehrenstein JK, et al. Type of cancer treatment and cognitive symptoms in working cancer survivors: an 18-month follow-up study. J Cancer Surviv. 2020;14(2):158\u201367.","journal-title":"J Cancer Surviv"},{"issue":"6","key":"1458_CR50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11764-019-00793-7","volume":"13","author":"I Ramsey","year":"2019","unstructured":"Ramsey I, et al. Cancer survivors who fully participate in the PROFILES registry have better health-related quality of life than those who drop out. J Cancer Surviv. 2019;13(6):829\u201339.","journal-title":"J Cancer Surviv"},{"issue":"12","key":"1458_CR51","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s11136-018-1979-0","volume":"27","author":"BH de Rooij","year":"2018","unstructured":"de Rooij BH, et al. Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: the population-based PROFILES registry. Qual Life Res. 2018;27(12):3313\u201324.","journal-title":"Qual Life Res"},{"issue":"3","key":"1458_CR52","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00277-022-05070-9","volume":"102","author":"NC van Yperen","year":"2023","unstructured":"van Yperen NC, et al. Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA). Ann Hematol. 2023;102(3):641\u20139.","journal-title":"Ann Hematol"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01458-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-023-01458-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01458-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T12:01:13Z","timestamp":1739448073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-023-01458-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1458"],"URL":"https:\/\/doi.org\/10.1007\/s11764-023-01458-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3169666\/v1","asserted-by":"object"}]},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,27]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from a certified Medical Ethics Committee (Maxima Medical Centre in Veldhoven, the Netherlands; 0734).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}